Preclinical mouse models and methods for the discovery of the causes and treatments of atherosclerosis

Author： Hewing Bernd   Fisher Edward A  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.7, Iss.3, 2012-03, pp. : 207-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Apoptosis and Efferocytosis in Mouse Models of Atherosclerosis

By  

Current Drug Targets, Vol. 8, Iss. 12, 2007-12 ,pp. : 1288-1296

Bentham Science Publishers

Access to resources Recommend Favorite

Transgenic Mouse Models of Tauopathy in Drug Discovery

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 4, 2010-08 ,pp. : 403-428

Bentham Science Publishers

Access to resources Recommend Favorite

Lipoprotein Size and Susceptibility to Atherosclerosis — Insights from Genetically Modified Mouse Models

By  

Current Drug Targets, Vol. 9, Iss. 3, 2008-03 ,pp. : 174-189

Bentham Science Publishers

Access to resources Recommend Favorite

An update on mouse brain tumor models in cancer drug discovery

By Hambardzumyan Dolores   Lyustikman Yelena   Holland Eric C  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 11, 2007-11 ,pp. : 1435-1451

Informa Healthcare

Access to resources Recommend Favorite

Applications and Limitations of Genetically Modified Mouse Models in Drug Discovery and Development

By  

Current Drug Metabolism, Vol. 9, Iss. 5, 2008-06 ,pp. : 419-438

Bentham Science Publishers

Access to resources Recommend Favorite